MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
29.76
+0.65 (2.23%)
At close: Apr 24, 2026, 4:00 PM EDT
29.49
-0.27 (-0.91%)
After-hours: Apr 24, 2026, 7:24 PM EDT

MapLight Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22
1,310767---
Enterprise Value
1,0111,053---
Last Close Price
29.7617.57---
PB Ratio
2.861.67---
P/TBV Ratio
2.861.67---
Debt / Equity Ratio
0.010.010.060.080.30
Net Debt / Equity Ratio
-0.65-0.65-0.89-1.04-1.02
Net Debt / EBITDA Ratio
1.781.781.241.300.70
Net Debt / FCF Ratio
2.162.161.281.410.78
Quick Ratio
18.8018.806.835.432.20
Current Ratio
20.0120.017.205.692.54
Return on Equity (ROE)
-56.19%-56.19%-83.21%-120.91%-
Return on Assets (ROA)
-34.29%-34.29%-45.41%-54.74%-
Return on Capital Employed (ROCE)
-36.50%-36.50%-68.60%-74.70%-116.60%
Earnings Yield
-12.30%-21.02%---
FCF Yield
-10.58%-18.08%---
Buyback Yield / Dilution
-1079.16%-1079.16%-11.60%-18.43%-
Updated Mar 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q